Page last updated: 2024-09-04

beta-lactams and 1-methylquinolinium

beta-lactams has been researched along with 1-methylquinolinium in 1 studies

Compound Research Comparison

Studies (beta-lactams)	Trials (beta-lactams)	Recent Studies (post-2010) (beta-lactams)	Studies (1-methylquinolinium)	Trials (1-methylquinolinium)	Recent Studies (post-2010) (1-methylquinolinium)
7,579	179	3,395	11	0	6

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ban, L; Fang, Z; Li, X; Li, Y; Liu, T; Liu, Z; Lu, Y; Sun, N; Wong, KY; Yao, X; Yuan, W	1

Other Studies

1 other study(ies) available for beta-lactams and 1-methylquinolinium

Article	Year
A quinoline-based FtsZ inhibitor for the study of antimicrobial activity and synergistic effects with β-lactam antibiotics. Journal of pharmacological sciences, 2018, Volume: 137, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cell Division; Cytoskeletal Proteins; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Synergism; Escherichia coli; GTP Phosphohydrolases; Methicillin-Resistant Staphylococcus aureus; Polymerization; Quinolinium Compounds; Vancomycin-Resistant Enterococci	2018

Article

Year

A quinoline-based FtsZ inhibitor for the study of antimicrobial activity and synergistic effects with β-lactam antibiotics.

Journal of pharmacological sciences, 2018, Volume: 137, Issue:3

Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cell Division; Cytoskeletal Proteins; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Synergism; Escherichia coli; GTP Phosphohydrolases; Methicillin-Resistant Staphylococcus aureus; Polymerization; Quinolinium Compounds; Vancomycin-Resistant Enterococci

2018